![]() |
市場調查報告書
商品編碼
2129273
細胞培養乳製品配料市場預測至2034年-全球分析(按產品類型、配料類型、細胞來源、生產技術、配料功能、應用、最終用戶和地區分類)Cell-Cultured Dairy Ingredients Market Forecasts to 2034 - Global Analysis By Product Type, Ingredient Type, Cell Source, Production Technology, Ingredient Function, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球細胞培養乳成分市場規模將達到 24 億美元,並在預測期內以 16.0% 的複合年成長率成長,到 2034 年將達到 79 億美元。
細胞培養乳成分是指透過細胞農業而非傳統畜牧養殖方式生產的乳源性蛋白質、脂肪及其他成分。這些原料是在生物反應器中,於受控條件下培養乳腺上皮細胞或經過基因改造可表達乳蛋白質的微生物宿主而製成的。所得化合物與傳統方法所得的乳成分具有相同的分子結構與功能特性。這種生產方法不僅無需使用泌乳動物,還能減少對環境的影響,並為那些希望解決傳統乳製品採購相關倫理問題的生產者提供了一種永續的替代方案。
永續性和倫理議題
由於人們環保意識的增強以及對傳統酪農倫理問題的日益關注,製造商正擴大採用細胞培養衍生的乳製品原料作為永續的替代方案。細胞農業減少溫室氣體排放和土地佔用,迫使各大品牌重新評估產品配方。消費者對無動物成分食品的需求不斷成長,也加速了對微發酵技術的投資。這些對永續性的需求正在重塑全球食品飲料產業的供應鏈策略。
擴大生產規模的挑戰
從實驗室規模的細胞培養過渡到商業生物反應器生產,對細胞培養乳成分生產商而言,面臨巨大的技術和經濟挑戰。要實現與傳統乳蛋白質生產相當的成本,需要對專用發酵基礎設施和下游加工設施進行大量投資。在工業規模上維持無菌培養並確保穩定的產量,其複雜性增加了營運風險。這些生產瓶頸限制了供給能力,並阻礙了新參與企業的市場准入。
擴大與餐飲業的合作關係
細胞培養乳製品原料生產商與餐飲服務供應商之間的策略合作,為市場滲透和消費者認可度的提升提供了巨大的成長機會。快餐店和烘焙連鎖店正日益尋求永續的替代原料,以履行其企業永續發展承諾。聯合產品開發舉措能夠加速配方最佳化並擴大生產能力。此類合作使技術供應商能夠利用其現有的分銷網路,同時幫助餐飲服務品牌透過創新的潔淨標示乳製品解決方案實現產品差異化。
消費者懷疑態度和標籤問題
消費者對細胞培養乳成分安全性的持續質疑,嚴重威脅其在市場上的廣泛應用。標籤術語和監管分類方面的混亂阻礙了透明資訊的有效傳播。傳統乳製品產業對細胞培養產品的遊說活動加劇了市場競爭,並影響了公眾認知。為因應這些挑戰,必須增加對消費者意識宣傳活動和清晰法規結構的投入,以建立信任,幫助消費者做出明智的購買決策。
疫情初期,設施准入限制擾亂了細胞培養乳製品的實驗室研究,並延誤了生產試驗。疫情中期,傳統乳製品供應鏈的脆弱性凸顯,凸顯了本地細胞農業生產的價值。疫情後,隨著投資人意識到替代蛋白價值鏈的韌性優勢,市場在創業投資和監管參與度的提升下獲得了發展動力。
在預測期內,乳清蛋白原料細分市場預計將佔據最大佔有率。
預計在預測期內,乳清蛋白原料領域將佔據最大的市場佔有率,這主要得益於運動營養產業的穩定需求以及基於細胞培養的乳清蛋白生產技術的相對成熟。領先的生產商正將這些原料添加到蛋白質強化產品中,以滿足消費者對永續蛋白質來源的需求。乳清蛋白在乳化方面的多功能性使其成為產品開發人員的必備原料。生物反應器產量的提高正在鞏固該領域在市場中的主導地位。
預計在預測期內,細胞培養乳清蛋白細分市場將呈現最高的複合年成長率。
在預測期內,細胞培養乳清蛋白細分市場預計將呈現最高的成長率,這主要得益於運動營養領域對高純度、永續蛋白質替代品的需求不斷成長。乳清蛋白優異的胺基酸組成和快速吸收特性使其深受注重運動表現的消費者青睞。微發酵技術的進步正在降低生產成本並提高規模化生產能力。關鍵市場對新食品應用的法規核准正在加速乳清蛋白的商業性化應用和生產擴張。
在預測期內,北美預計將佔據最大的市場佔有率,這主要得益於該地區細胞農業新創企業的集中以及對替代蛋白技術的創業投資投資。美國憑藉其先進的生物技術基礎設施和新型食品配料法規結構,在該領域處於領先地位。該地區的主要生產商正與微發酵公司合作,以確保永續的供應鏈。消費者對植物來源產品的強勁需求進一步鞏固了北美的市場主導地位。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於中國和印度食品加工業的擴張,以及政府對替代蛋白研發的支持。該地區不斷壯大的中產階級正在推動對永續乳製品替代品和強化蛋白質產品的需求。國際細胞培養乳製品公司正在東南亞各地建立生產設施並合作。對生物技術基礎設施和發酵技術的投資正在加速該地區的市場發展和商業化。
According to Stratistics MRC, the Global Cell-Cultured Dairy Ingredients Market is accounted for $2.4 billion in 2026 and is expected to reach $7.9 billion by 2034 growing at a CAGR of 16.0% during the forecast period. Cell-cultured dairy ingredients refer to milk-derived proteins, fats, and components produced through cellular agriculture rather than traditional animal farming. These ingredients are created by cultivating mammary epithelial cells or microbial hosts engineered to express dairy proteins in bioreactor environments under controlled conditions. The resulting compounds exhibit molecular structures and functional properties identical to conventionally derived dairy components. This production method eliminates the need for lactating animals while offering sustainable alternatives for manufacturers seeking to reduce environmental impact and address ethical concerns with conventional dairy sourcing.
Sustainability and Ethical Concerns
Increasing environmental awareness and ethical concerns regarding conventional dairy farming are driving manufacturers to adopt cell-cultured dairy ingredients as sustainable alternatives. The reduction in greenhouse gas emissions and land use associated with cellular agriculture is compelling brands to reformulate products. Consumer demand for cruelty-free food options is accelerating investment in precision fermentation technologies. These sustainability imperatives are reshaping supply chain strategies across the global food and beverage industry.
Scale-Up Production Challenges
The transition from laboratory-scale cell cultivation to commercial bioreactor production presents significant technical and economic challenges for cell-cultured dairy ingredient manufacturers. Achieving cost parity with conventionally produced dairy proteins requires substantial capital investment in specialized fermentation infrastructure and downstream processing equipment. The complexity of maintaining sterile cultures at industrial scale while ensuring consistent yield increases operational risks. These production bottlenecks constrain supply capacity and limit market accessibility for emerging players.
Foodservice Partnership Expansion
Strategic partnerships between cell-cultured dairy ingredient producers and foodservice operators present substantial growth opportunities for market penetration and consumer acceptance. Quick-service restaurants and bakery chains are increasingly seeking sustainable ingredient alternatives to meet corporate sustainability commitments. Collaborative product development initiatives can accelerate formulation optimization and scale manufacturing capabilities. These alliances enable technology providers to leverage existing distribution networks while helping foodservice brands differentiate their offerings through innovative clean-label dairy solutions.
Consumer Skepticism and Labeling
Persistent consumer skepticism regarding the safety of cell-cultured dairy ingredients poses a significant threat to widespread market adoption. Confusion over labeling terminology and regulatory classification creates barriers to transparent consumer communication. Traditional dairy industry lobbying efforts against cellular agriculture products are intensifying competitive pressures and influencing public perception. These challenges necessitate substantial investment in consumer education campaigns and clear regulatory frameworks to build trust and facilitate informed purchasing decisions.
The pandemic initially disrupted laboratory research and delayed production trials for cell-cultured dairy ingredients due to facility access restrictions. During the mid-pandemic period, supply chain vulnerabilities in conventional dairy highlighted the value of localized cellular agriculture production. Post-pandemic, the market has gained momentum with increased venture capital funding and regulatory engagement as investors recognize resilience benefits of alternative protein chains.
The whey protein ingredients segment is expected to be the largest during the forecast period
The whey protein ingredients segment is expected to account for the largest market share during the forecast period, due to its established demand across sports nutrition applications and the relative maturity of cell-cultured whey production technologies. Major manufacturers are incorporating these ingredients into protein-fortified products to meet consumer demand for sustainable protein sources. The versatility of whey proteins in emulsification makes them indispensable for formulators. Improvements in bioreactor yield are consolidating this segment's market leadership.
The cell-cultured whey proteins segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the cell-cultured whey proteins segment is predicted to witness the highest growth rate, driven by accelerating demand from sports nutrition sectors seeking high-purity sustainable protein alternatives. The superior amino acid profile and rapid absorption characteristics of whey proteins make them attractive for performance-oriented consumers. Advances in precision fermentation are reducing production costs and improving scalability. Regulatory approvals for novel food applications in key markets are catalyzing commercial adoption and manufacturing expansion.
During the forecast period, the North America region is expected to hold the largest market share, due to the concentration of cellular agriculture startups and venture capital investment in alternative protein technologies. The United States leads with advanced biotechnology infrastructure and regulatory frameworks for novel food ingredients. Major manufacturers in the region are partnering with precision fermentation companies to secure sustainable supply chains. Strong consumer demand for plant-based products further reinforces North America's market dominance.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to expanding food processing industries and government support for alternative protein research in China and India. The region's growing middle class is driving demand for sustainable dairy alternatives and protein-enriched products. International cell-cultured dairy companies are establishing production facilities and partnerships across Southeast Asia. Investments in biotechnology infrastructure and fermentation capabilities are accelerating regional market development and commercialization timelines.
Key players in the market
Some of the key players in Cell-Cultured Dairy Ingredients Market include Perfect Day Inc., Remilk Ltd., New Culture, Formo Bio GmbH, Impossible Foods Inc., The EVERY Company, Standing Ovation, Imagindairy Ltd., Bon Vivant, Those Vegan Cowboys, Clara Foods, De Novo Foodlabs, Change Foods, Geltor Inc., Dyadic International Inc., and DSM-Firmenich AG..
In August 2026, Perfect Day Inc. launched a commercial-scale precision fermentation facility for whey protein production, achieving significant cost reductions and enabling broader food industry adoption of cell-cultured dairy ingredients.
In July 2026, Remilk Ltd. secured regulatory approval for its cell-cultured casein ingredients in the European Union, paving the way for commercial distribution across member states and accelerated partnership negotiations with major dairy alternative producers.
In June 2026, The EVERY Company expanded its portfolio of cell-cultured dairy proteins through a strategic partnership with a global ingredient distributor, significantly increasing market reach and enabling faster scale-up of production capacity for food manufacturers.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.